TBC-11299

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTBC-11299
Drug Alias Namecardiovascular therapeutics (Texas)TBC-11299
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEncysive Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A